What Happened?
Boston, MA-based TearClear Appointed Robert Dempsey as Chief Executive Officer
About the Company
TearClear is an emerging ophthalmic pharmaceutical company with the goal of disrupting the way current topical medications are delivered to the ocular surface. Our lead product candidates in glaucoma will pave the way for future indications across multiple programs in development.
About the Person
Robert Dempsey is Chief Executive Officer at TearClear. Previously, Robert held various senior HR leadership roles in the industry.
Info Source
News
Short Profile